Home and small-business security company ADT is all about making people feel safe. Now, as a result of a partnership with financial wellness platform Addition Wealth, its employees are feeling more ...

A partitioned-survival lifetime model (2025 USD) compared ADT alone with seven intensification strategies across PFS, post-progression, and death, using published survival curves and literature-based ...

Shares of ADT were lower after the company logged lower a fourth-quarter profit and said it expects profit and revenue to be flat for the year. The stock slipped 5.4%, to $7.59, in premarket trading ...

The company's bottom line totaled $146 million, or $0.17 per share. This compares with $197 million, or $0.20 per share, last year. Excluding items, ADT Inc. reported adjusted earnings of $186 million ...

BOCA RATON, Fla. (AP) — BOCA RATON, Fla. (AP) — ADT Inc. (ADT) on Monday reported fourth-quarter net income of $145 million. The Boca Raton, Florida-based company said it had net income of 17 cents ...

ADT on Tuesday announced an interesting new acquisition for anyone looking to the future of home security-- and it's no surprise AI is a part of the story. In a $170 million deal, ADT has purchased ...

BOCA RATON, Fla. — ADT, a provider of smart home solutions serving residential and small business customers in the U.S., has announced that it has acquired Origin Wireless, Inc. (d/b/a “Origin AI” and ...

ADT (Nasdaq: ADT) has acquired Origin Wireless, bringing the company’s AI sensing platform and related intellectual property into the ADT ecosystem in a move aimed at advancing intelligent home ...

In a pooled analysis, longer duration of androgen deprivation therapy (ADT) was associated with nonlinear improvements in outcomes in men with prostate cancer receiving definitive radiotherapy.

ADT is a defensive, cash-generative business trading below intrinsic value, assuming it increases its ROIC. State Farm and Apollo, holding ~27% combined, may sell shares, potentially pressuring ADT’s ...

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond 9 to 12 months of ADT. HealthDay News — Increasing duration of androgen deprivation therapy (ADT) ...

Androgen deprivation therapy (ADT), also called hormone therapy, is a common treatment for metastatic prostate cancer. It works by starving the cancer of testosterone, which fuels the tumor’s growth.